Search Results - Azad Bonni

Azad Bonni

Azad Bonni is a Canadian and American neuroscientist of Kurdish origin. The focus of his research is to understand the mechanisms of neuronal connectivity in the brain. From October 2012 until June 30, 2019, he was the Edison Professor of Neuroscience and Chairman of the Department of Neuroscience at Washington University School of Medicine. As of July 1, 2019, he is SVP and head of neuroscience and rare diseases research and early development at Roche in Basel, Switzerland. Provided by Wikipedia
  • Showing 1 - 7 results of 7
Refine Results
  1. 1

    Sumoylated SnoN interacts with HDAC1 and p300/CBP to regulate EMT-associated phenotypes in mammary organoids by Ayan Chanda, Anusi Sarkar, Lili Deng, Azad Bonni, Shirin Bonni

    Published in Cell Death and Disease (2023-07-01)
    Get full text
    Article


  2. 2

    RNF8/UBC13 ubiquitin signaling suppresses synapse formation in the mammalian brain by Pamela Valnegri, Ju Huang, Tomoko Yamada, Yue Yang, Luis A. Mejia, Ha Y. Cho, Anna Oldenborg, Azad Bonni

    Published in Nature Communications (2017-11-01)
    Get full text
    Article


  3. 3

    MeCP2 represses the activity of topoisomerase IIβ in long neuronal genes by Sabin A. Nettles, Yoshiho Ikeuchi, Katheryn B. Lefton, Ladan Abbasi, Alyssa Erickson, Chibueze Agwu, Thomas Papouin, Azad Bonni, Harrison W. Gabel

    Published in Cell Reports (2023-12-01)
    Get full text
    Article


  4. 4

    Targeted ASO-mediated Atp1a2 knockdown in astrocytes reduces SOD1 aggregation and accelerates disease onset in mutant SOD1 mice. by Abhirami K Iyer, Kathleen M Schoch, Anthony Verbeck, Grant Galasso, Hao Chen, Sarah Smith, Anna Oldenborg, Timothy M Miller, Celeste M Karch, Azad Bonni

    Published in PLoS ONE (2023-01-01)
    Get full text
    Article


  5. 5

    Author Correction: Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials by Gennaro Pagano, Dylan Trundell, Tanya Simuni, Nicola Pavese, Kenneth Marek, Ronald B. Postuma, Nima Shariati, Annabelle Monnet, Emma Moore, Evan W. Davies, Hanno Svoboda, Nathalie Pross, Azad Bonni, Tania Nikolcheva, for the PASADENA Investigators, Prasinezumab Study Group

    Published in npj Parkinson's Disease (2025-08-01)
    Get full text
    Article


  6. 6

    Time-to-event analysis mitigates the impact of symptomatic therapy on therapeutic benefit in Parkinson’s disease trials by Gennaro Pagano, Dylan Trundell, Tanya Simuni, Nicola Pavese, Kenneth Marek, Ronald B. Postuma, Nima Shariati, Annabelle Monnet, Emma Moore, Evan W. Davies, Hanno Svoboda, Nathalie Pross, Azad Bonni, Tania Nikolcheva, for the PASADENA Investigators, Prasinezumab Study Group

    Published in npj Parkinson's Disease (2025-07-01)
    Get full text
    Article


  7. 7

    Characterization of a Mouse Model of Börjeson-Forssman-Lehmann Syndrome by Cheng Cheng, Pan-Yue Deng, Yoshiho Ikeuchi, Carla Yuede, Daofeng Li, Nicholas Rensing, Ju Huang, Dustin Baldridge, Susan E. Maloney, Joseph D. Dougherty, John Constantino, Arezu Jahani-Asl, Michael Wong, David F. Wozniak, Ting Wang, Vitaly A. Klyachko, Azad Bonni

    Published in Cell Reports (2018-11-01)
    Get full text
    Article


Search Tools: